Shenzhen New Industries Biomedical (300832) — Cash Flow Quality Index
Shenzhen New Industries Biomedical (300832) has a Cash Flow Quality Index of 1.40x as of September 2025. Operating cash flow of CN¥606.21 Million exceeds net income of CN¥433.73 Million, indicating high earnings quality where cash backs reported profits. Explore Shenzhen New Industries Biomedical cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Shenzhen New Industries Biomedical Cash Flow Quality Index (2012–2024)
Historical Cash Flow Quality Index for Shenzhen New Industries Biomedical across 13 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see cash efficiency ratio of Shenzhen New Industries Biomedical.
Annual Cash Flow Quality Index for Shenzhen New Industries Biomedical (2012–2024)
Year-by-year earnings quality comparison for Shenzhen New Industries Biomedical.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 0.74x | CN¥1.36 Billion | CN¥1.83 Billion | ▼ -13.5% |
| 2023 | 0.86x | CN¥1.42 Billion | CN¥1.65 Billion | ▲ +18.3% |
| 2022 | 0.72x | CN¥962.39 Million | CN¥1.33 Billion | ▼ -8.7% |
| 2021 | 0.79x | CN¥773.22 Million | CN¥973.70 Million | ▼ -23.6% |
| 2020 | 1.04x | CN¥976.65 Million | CN¥939.15 Million | ▼ -3.4% |
| 2019 | 1.08x | CN¥831.73 Million | CN¥772.61 Million | ▲ +6.4% |
| 2018 | 1.01x | CN¥701.97 Million | CN¥694.00 Million | ▲ +3.7% |
| 2017 | 0.97x | CN¥524.73 Million | CN¥538.21 Million | ▼ -9.5% |
| 2016 | 1.08x | CN¥486.81 Million | CN¥451.69 Million | ▼ -12.2% |
| 2015 | 1.23x | CN¥305.93 Million | CN¥249.12 Million | ▲ +22.5% |
| 2014 | 1.00x | CN¥253.47 Million | CN¥252.87 Million | ▲ +2.4% |
| 2013 | 0.98x | CN¥138.33 Million | CN¥141.27 Million | ▲ +31.8% |
| 2012 | 0.74x | CN¥55.80 Million | CN¥75.12 Million | — |